ERAS pathways may reduce opioid exposure and shorten hospital stays in flap reconstructionERAS Pathways May Reduce Opioid Use in Reconstruction Surgery
Frontiers in MedicinePublished July 30, 2026DOI ↗Editorial oversight: Dr. Lars van Dijk, PhD · Surgical, Procedural & Diagnostic
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider ERAS pathways to potentially reduce opioid exposure and hospital stay duration in flap reconstructions.
This structured narrative review synthesizes evidence regarding the implementation of Enhanced Recovery After Surgery (ERAS) pathways, fast-track protocols, or accelerated recovery bundles for patients undergoing flap-based reconstruction compared to conventional perioperative care.
The authors conclude that ERAS pathways are most consistently associated with shorter hospital stays and earlier mobilization or feeding. Additionally, these protocols were associated with reduced opioid exposure. Safety outcomes, including flap compromise, readmission, and return to theatre, were generally not worse in the studies cited by the authors.
Several limitations impact the certainty of these findings, including the reliance on observational designs and single-center implementation studies. The review notes significant clinical heterogeneity regarding ERAS bundle components, flap types, and outcome definitions. Furthermore, variable adherence and inconsistent reporting across studies limit the ability to draw definitive conclusions.
Clinically, ERAS appears feasible and potentially beneficial for flap reconstruction when tailored to specific flap types, anatomic sites, and patient comorbidities. The authors suggest cautious implementation and local auditing rather than universal adoption of a single protocol.
How this fits prior evidence
This finding extends the evidence regarding ERAS protocols in surgical settings. Specifically, it builds upon existing evidence that ERAS protocols may reduce opioid use and shorten stays for patients undergoing orthognathic surgery. While this review focuses on flap-based reconstruction, it reinforces the broader utility of accelerated recovery bundles in reducing opioid exposure and improving recovery timelines across different surgical specialties.
Researchers looked at how Enhanced Recovery After Surgery (ERAS) pathways affect patients undergoing flap-based reconstruction. These programs, often called fast-track or accelerated recovery bundles, aim to streamline the healing process after complex reconstructive procedures.
The review found that ERAS pathways were most consistently linked to shorter hospital stays and earlier mobilization and feeding for patients. Additionally, these protocols were associated with a reduction in opioid exposure. Safety measures, such as flap compromise, readmission rates, and returns to the operating room, were generally not worse when using these accelerated methods.
Because this review relied on observational studies and reports from single centers, the evidence is not definitive. There was also inconsistent reporting and varied ways of following the protocols across different hospitals. While ERAS appears feasible for reconstruction, it should be tailored to the specific flap type and the patient's unique health needs before being adopted.
What this means for you:
ERAS pathways may shorten hospital stays and reduce opioid use in flap reconstruction surgery.
Common questions
Can ERAS pathways help with recovery after reconstructive surgery?
Yes, the review found that ERAS pathways were most consistently associated with shorter hospital stays and earlier mobilization or feeding. These programs are designed to streamline the recovery process for patients undergoing flap-based reconstruction.
Does this method reduce the need for pain medication?
The study found that ERAS pathways were associated with reduced opioid exposure for patients. This suggests these protocols may help manage pain while limiting the amount of opioid medication a patient receives during their recovery.
Is it safe to use accelerated recovery bundles for flap reconstruction?
Safety outcomes, such as flap compromise and readmission rates, were generally not worse in the studies reviewed. However, because the evidence comes from observational designs with inconsistent reporting, you should discuss specific risks with your surgical team.
BackgroundEnhanced Recovery After Surgery (ERAS) pathways are increasingly used in reconstructive plastic surgery, but flap reconstruction presents specific challenges, including dependence on stable microvascular perfusion, procedure-specific immobilization, donor-site morbidity, and heterogeneous anatomic indications. Because available studies differ substantially in surgical setting, flap type, ERAS bundle composition, comparator care, and outcome reporting, this article is presented as a structured narrative synthesis rather than a de novo meta-analysis.MethodsPubMed, Embase, Web of Science, and Google Scholar were searched for studies and reviews published from 1997 to 14 June 2026 that addressed ERAS, fast-track, or accelerated recovery pathways in flap reconstruction or closely related reconstructive plastic surgery settings. The review question was defined using PICOS: adult or pediatric patients undergoing flap-based reconstruction; perioperative ERAS or accelerated recovery bundles; conventional perioperative care or pre-implementation practice; clinical, recovery, safety, and patient-centered outcomes; and randomized, prospective, retrospective, implementation, and systematic-review designs. Because ERAS bundles, flap types, and outcome definitions were clinically heterogeneous, no formal quantitative pooling was performed.ResultsAcross breast reconstruction, head and neck free-flap reconstruction, perineal or pelvic reconstruction, lower-limb reconstruction, and selected flap-based wound procedures, ERAS pathways were most consistently associated with shorter hospital stay, earlier mobilization or feeding, and reduced opioid exposure. Safety outcomes, including flap compromise, readmission, and return to theatre, were generally not worse in the cited studies, but certainty is limited by observational designs, single-center implementation studies, variable adherence, and inconsistent reporting. The components most relevant to flap surgery are preoperative optimization, multimodal analgesia, goal-directed fluid therapy, protocolized flap monitoring, early but protected mobilization, nutrition, and explicit nursing-clinician coordination.ConclusionsERAS appears feasible and potentially beneficial in flap reconstruction when adapted to flap type, anatomic site, comorbidity burden, and reconstructive goals. The current evidence supports cautious implementation and local auditing rather than universal adoption of a single protocol. Future research should use plastic surgery-specific ERAS definitions, report study-level outcomes transparently, separate reconstructive from aesthetic indications where clinically appropriate, and prioritize long-term function, patient-reported outcomes, cost, and flap-specific safety endpoints.
